Certain substances on the Domestic Substances List used primarily as pharmaceuticals
CAS RN | Common Pharmaceutical Name | Canada Gazette Notice | Final Screening Assessment | Conclusion on Section 64 criteria |
---|---|---|---|---|
50-06-6 | Phenobarbital | HTML | HTML | Does not meet |
50-18-0 | Cyclophosphamide | |||
55-86-7 | Mechlorethamine | |||
55-98-1 | Busulfan | |||
56-75-7 | Chloramphenicol | |||
57-41-0 | Phenytoin | |||
68-22-4 | Norethindrone | |||
71-58-9 | Medroxyprogesterone | |||
81-81-2 | Warfarin | |||
126-07-8 | Griseofulvin | |||
148-82-3 | Melphalan | |||
154-93-8 | Carmustine | |||
305-03-3 | Chlorambucil | |||
443-48-1 | Metronidazole | |||
446-86-6 | Azathioprine | |||
604-75-1 | Oxazepam | |||
7481-89-2 | Zalcitabine | |||
13010-47-4 | Lomustine | |||
18883-66-4 | Streptozocin | |||
20830-81-3 | Daunorubicin | |||
29767-20-2 | Teniposide | |||
30516-87-1 | Zidovudine | |||
51264-14-3 | Amsacrine | |||
10540-29-1 | Tamoxifen | HTML | HTML | |
23214-92-8 | Doxorubicin | HTML | HTML | |
33419-42-0 | Etoposide | HTML | HTML | |
59865-13-3 | Cyclosporin A | HTML | HTML | |
63798-73-2 | Cyclosporin E |
Date | Substances Affected | Activity |
---|---|---|
February 21, 2015 | All 28 substances | Publication of the final screening assessments in the Canada Gazette Part I: Vol. 149, No. 8 - February 21, 2015. |
March 22, 2014 | All 28 substances | Publication of the draft screening assessments in the Canada Gazette, Part I: Vol. 148, No. 12 - March 22, 2014 and start of 60-day public comment period, ending May 21, 2014. |
Background
The substances were flagged during the categorization process as high hazard by Health Canada based on classifications for carcinogenicity or developmental toxicity, and/or as priorities by Environment Canada based on concerns regarding persistence, bioaccumulation and inherent toxicity to non-human organisms.
If you have questions or comments, please contact us. Indicate on the envelope or subject line "Certain Substances on the Domestic Substances List Used Primarily as Pharmaceuticals".
Page details
- Date modified: